An observational study in Repeated Implantation Failure, sponsored by Assaf-Harofeh Medical Center. Status unknown. Open to female participants aged 18 Years to 40 Years, including healthy volunteers. Per ClinicalTrials.gov, last updated 2013-09-02.
Sponsored by Assaf-Harofeh Medical Center · Observational
Pipelle was found to increase pregnancy and implantation rates in women undergoing IVF treatment in general, and in particular in repeated implantation failure (RIF). However, there is virtually no data regarding the optimal timing for the pipelle.
The current study aims to compare between follicular and luteal pipelle on pregnancy rate in RIF patients.
Assaf-Harofeh Medical Center is the lead sponsor of 258 studies on the registry; 40 are open to participants now.
Counted across the registry records on this site, refreshed daily.
Women diagnosed with repeated implantation failure (RIF) who are undergoing IVF treatment.
Women diagnosed with RIF who are going to start a new IVF treatment
Exclusion Criteria:
Known hydrosalpinx body mass index (BMI) >29 kg/m2 or \<18 kg/m2 Low ovarian response
Pregnancy rate
Time frame: April, 2014
No study locations are listed for this record.
This study is status unknown, as verified in Aug 2013. You cannot join it, but the record below documents what was studied.
Get an email when the registry record changes — status, dates, results — or when someone posts here.
Sign in to followQuestions and observations about this study, from anyone following it. Not medical advice, and not a channel to the study team — their contact details are on the registry record.
Sign in to join the discussion. Reading takes no account; posting does. You choose a display name, and a pseudonym is the default.
Nothing here yet. If you are running this trial, taking part in it, or weighing whether to, this is the place to say so.
Assaf-Harofeh Medical Center